Tag Archives: Alethia Young

Credit Suisse Issues a Buy Rating on Coherus Biosciences

479630.jpg

Credit Suisse analyst Alethia Young maintained a Buy rating on Coherus Biosciences (NASDAQ: CHRS) on April 19 and set a price target of $38. The company’s shares closed yesterday at $18.75. According to TipRanks.com, Young is a 1-star analyst with

Credit Suisse Issues a Hold Rating on Amgen Inc

477092.jpg

Credit Suisse analyst Alethia Young maintained a Hold rating on Amgen Inc (NASDAQ: AMGN) yesterday and set a price target of $178. The company’s shares opened today at $163.78. According to TipRanks.com, Young is a 2-star analyst with an average

Vertex Pharmaceuticals was Downgraded to a Hold Rating at Credit Suisse

477090.jpg

Vertex Pharmaceuticals (NASDAQ: VRTX) received a Hold rating and a $108 price target from Credit Suisse analyst Alethia Young yesterday. The company’s shares opened today at $107.24. According to TipRanks.com, Young is a 2-star analyst with an average return of

Analysts’ Top Healthcare Picks: CHRS, ACRS

470367.jpg

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Coherus Biosciences (NASDAQ: CHRS) and Aclaris Therapeutics Inc (NASDAQ: ACRS) with bullish sentiments. Coherus Biosciences (NASDAQ: CHRS) In a report released yesterday,

Credit Suisse Thinks Gilead Sciences’ Stock is Going to Recover

468785.png

Credit Suisse analyst Alethia Young maintained a Buy rating on Gilead Sciences (NASDAQ: GILD) on February 27 and set a price target of $79. The company’s shares closed yesterday at $70.48, close to its 52-week low of $65.38. According to

Analysts Offer Insights on Healthcare Companies: Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR)

467569.jpg

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR). Alexion Pharmaceuticals (NASDAQ: ALXN) In a report released yesterday,